About BFS Molecular
BFS Molecular is a company based in Budapest (Hungary) founded in 2017 was acquired by CareDx in March 2021. BFS Molecular offers products and services including Molecular Solutions. BFS Molecular operates in a competitive market with competitors including Oxford Immunotec, Immucor, Verici Dx, Olaris and Nephrosant, among others.
- Headquarter Budapest, Hungary
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BFS Molecular
BFS Molecular offers a comprehensive portfolio of products and services, including Molecular Solutions.
Provides pioneering molecular innovations for user applications and updates.
Funding Insights of BFS Molecular
Detailed funding history for BFS Molecular
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in BFS Molecular
BFS Molecular has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CareDx.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical solutions for transplant patients are developed and provided.
|
Locked | Locked | Locked |
Investor details for BFS Molecular
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BFS Molecular
Investment portfolio details for BFS Molecular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BFS Molecular
Detailed financials for BFS Molecular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bfs Molecular Comparisons
Peer comparison for BFS Molecular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BFS Molecular
BFS Molecular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Immunotec, Immucor, Verici Dx, Olaris and Nephrosant, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Immune markers are utilized by Oxford Immunotec for disease diagnostics.
|
|
| Locked | Locked | Locked |
Transfusion and transplantation diagnostic products are provided by Immucor.
|
|
| Locked | Locked | Locked |
Developer of diagnostic solutions for organ transplants
|
|
| Locked | Locked | Locked |
In-vitro diagnostics are developed for oncology, transplants, and neurodegeneration.
|
|
| Locked | Locked | Locked |
Developer of diagnostic solutions for kidney disorders
|
|
| Locked | Locked | Locked |
Molecular diagnostic tests for early graft injury detection are developed.
|
Detailed competitors of BFS Molecular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bfs Molecular
Complete news archive for BFS Molecular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BFS Molecular
BFS Molecular was founded in 2017.
BFS Molecular is headquartered in Budapest, Hungary.
Developer of diagnostics for post-transplantation care. The products include StemScan that detects post-transplant chimerism for hematopoietic stem cell transplant, OrganScan that detects donor-derived DNA post-transplant for a solid organ transplant, and Graftrack software for both the products to monitor the result. These diagnostics are based on next-generation sequencing technology.
BFS Molecular's top competitors include Olaris, Oxford Immunotec and Verici Dx.
BFS Molecular offers Molecular Solutions.
BFS Molecular has 1 investor. Key investors include CareDx.